According to FIGO 2018 staging for cervical cancer, which of the following can now be used to upgrade clinical stage even if physical examination suggests lower stage?

• A Cystoscopy findings showing bladder mucosal involvement
• B Serum SCC antigen levels > 3 ng/mL
• C PET-CT showing FDG-avid pelvic lymph nodes
• D MRI demonstrating parametrial involvement ✓

Explanation

FIGO 2018 revised cervical cancer staging to allow incorporation of imaging (MRI, CT, PET) and pathological findings to assign stage, whereas prior FIGO staging was purely clinical. MRI demonstrating parametrial involvement can upgrade a clinically Stage IB tumour to Stage IIB. PET-CT findings of lymph node involvement upgrade disease to Stage IIIC. SCC antigen level is not a staging criterion. This represents the most significant change in FIGO 2018.

Reference: Shaw's Textbook of Gynaecology, 17th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.